相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice
Peng Chen et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2021)
Empagliflozin Reduces Myocardial Extracellular Volume in Patients With Type 2 Diabetes and Coronary Artery Disease
Tamique Mason et al.
JACC-CARDIOVASCULAR IMAGING (2021)
Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1
Thomas A. Treibel et al.
JACC-CARDIOVASCULAR IMAGING (2020)
Direct Effects of Empagliflozin on Extracellular Matrix Remodelling in Human Cardiac Myofibroblasts: Novel Translational Clues to Explain EMPA-REG OUTCOME Results
Sean Kang et al.
CANADIAN JOURNAL OF CARDIOLOGY (2020)
A 24-step guide on how to design, conduct, and successfully publish a systematic review and meta-analysis in medical research
Taulant Muka et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)
Pooled summary of native T1 value and extracellular volume with MOLLI variant sequences in normal subjects and patients with cardiovascular disease
Ha Q. Vo et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2020)
Effect of Liraglutide on Cardiovascular Function and Myocardial Tissue Characteristics in Type 2 Diabetes Patients of South Asian Descent Living in the Netherlands: A Double-Blind, Randomized, Placebo-Controlled Trial
Elisabeth H. M. Paiman et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2020)
Examining the Relationship and Prognostic Implication of Diabetic Status and Extracellular Matrix Expansion by Cardiac Magnetic Resonance
Mohammad A. Khan et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2020)
Negative synergism of diabetes mellitus and obesity in patients with heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study
Selcuk Kucukseymen et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2020)
Identifying Cardiac Amyloid in Aortic Stenosis ECV Quantification by CT in TAVR Patients
Paul R. Scully et al.
JACC-CARDIOVASCULAR IMAGING (2020)
Myocardial Fibrosis in Heart Failure: Anti-Fibrotic Therapies and the Role of Cardiovascular Magnetic Resonance in Drug Trials
Matthew Webber et al.
CARDIOLOGY AND THERAPY (2020)
Comparative Study of the Effects of GLP1 Analog and SGLT2 Inhibitor against Diabetic Cardiomyopathy in Type 2 Diabetic Rats: Possible Underlying Mechanisms
Abdelaziz M. Hussein et al.
BIOMEDICINES (2020)
Incremental value of extracellular volume assessment by cardiovascular magnetic resonance imaging in risk stratifying patients with suspected myocarditis
Christoph Graeni et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2019)
The Extracellular Matrix in Ischemic and Nonischemic Heart Failure
Nikolaos G. Frangogiannis
CIRCULATION RESEARCH (2019)
Association of myocardial fibrosis and cardiovascular events: the multi-ethnic study of atherosclerosis
Bharath Ambale-Venkatesh et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2019)
Myocardial native-T1 times are elevated as a function of hypertrophy, HbA1c, and heart rate in diabetic adults without diffuse fibrosis
Bonnie Lam et al.
MAGNETIC RESONANCE IMAGING (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
The Myocardial Interstitium: The Principal Therapeutic Target of the 21st Century?
Erik B. Schelbert et al.
JACC-CARDIOVASCULAR IMAGING (2019)
Myocardial Extracellular Volume Fraction Adds Prognostic Information Beyond Myocardial Replacement Fibrosis
Eric Y. Yang et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2019)
Liraglutide alleviates cardiac fibrosis through inhibiting P4hα-1 expression in STZ-induced diabetic cardiomyopathy
Tong Zhao et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2019)
Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes
Gaurav S. Gulsin et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2019)
Myocardial Interstitial Fibrosis in Heart Failure Biological and Translational Perspectives
Arantxa Gonzalez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Myocardial Extracellular Volume Quantification by Cardiovascular Magnetic Resonance and Computed Tomography
Paul R. Scully et al.
CURRENT CARDIOLOGY REPORTS (2018)
Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat
Mitchel Tate et al.
DIABETES & VASCULAR DISEASE RESEARCH (2017)
Employing Extracellular Volume Cardiovascular Magnetic Resonance Measures of Myocardial Fibrosis to Foster Novel Therapeutics
Erik B. Schelbert et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2017)
Relationship Between Left Ventricular Structural and Metabolic Remodeling in Type 2 Diabetes
Eylem Levelt et al.
DIABETES (2016)
Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities
Ilaria Russo et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis
Kai-yue Diao et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2016)
Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission
Timothy C. Wong et al.
EUROPEAN HEART JOURNAL (2014)
Myocardial Extracellular Volume Expansion and the Risk of Recurrent Atrial Fibrillation After Pulmonary Vein Isolation
Tomas G. Neilan et al.
JACC-CARDIOVASCULAR IMAGING (2014)
Correction: Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms
Belén Picatoste et al.
PLoS One (2013)
Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid
Chun-jun Li et al.
CARDIOVASCULAR DIABETOLOGY (2012)
Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes
K. Huynh et al.
DIABETOLOGIA (2012)
Prognostic Impact of Myocardial Interstitial Fibrosis in Non-Ischemic Heart Failure - Comparison Between Preserved and Reduced Ejection Fraction Heart Failure
Tatsuo Aoki et al.
CIRCULATION JOURNAL (2011)
Prognostic Significance of Myocardial Fibrosis Quantification by Histopathology and Magnetic Resonance Imaging in Patients With Severe Aortic Valve Disease
Clerio F. Azevedo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Noninvasive Detection of Fibrosis Applying Contrast-Enhanced Cardiac Magnetic Resonance in Different Forms of Left Ventricular Hypertrophy Relation to Remodeling
Andre Rudolph et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy
Sophie Van Linthout et al.
BASIC RESEARCH IN CARDIOLOGY (2008)
Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats
Manuela Aragno et al.
ENDOCRINOLOGY (2008)
Myocardial fibrosis in chronic kidney disease: potential benefits of torasemide
Begona Lopez et al.
KIDNEY INTERNATIONAL (2008)
Reduced cardiac expression of plasminogen activator inhibitor 1 and transforming growth factor beta(1) in obese Zucker rats by perindopril
JE Toblli et al.
HEART (2005)
分享论文
